Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 15 March

Sam Kanaan
March 15, 2024

Morning Bell 14 March

Sophia Mavridis
March 14, 2024

Morning Bell 13 March

Sam Kanaan
March 13, 2024

Morning Bell 12 March

Sam Kanaan
March 12, 2024

Morning Bell 11 March

Sam Kanaan
March 11, 2024

Weekly Wrap 8 March

Sophia Mavridis
March 8, 2024

Morning Bell 8 March

Sam Kanaan
March 8, 2024

Morning Bell 7 March

Sophia Mavridis
March 7, 2024

Morning Bell 6 March

Sam Kanaan
March 6, 2024

Morning Bell 5 March

Sam Kanaan
March 5, 2024

Morning Bell 4 March

Sophia Mavridis
March 4, 2024

Weekly Wrap 1 March

Grady Wulff
March 1, 2024